GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, XDH |
11.5107 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, XDH |
11.5107 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
10.2683 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9 |
9.32691 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AR, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FABP3, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP2, MMP9, NUAK1, PGR, SMAD3, SRC, TEK, XDH |
9.24021 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, FABP3, FABP4, GPR35, HCAR2, HSD11B1, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR7, INSR, KDR, MET, PPARA, SMAD3, SRC, TEK, XDH |
9.24021 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CYP1B1, DRD2, EGFR, F10, F3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, SRC, TEK, XDH |
8.47103 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, XDH |
8.34106 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, F10, F3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SRC, TEK, XDH |
8.30483 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, EGFR, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, MET, PPARA |
7.77257 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
7.77257 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, AR, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, PPARA, SMAD3, SRC, TEK |
7.68837 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
7.65444 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALOX15, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, FABP4, HSPA1A, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, PPARA, SMAD3, SRC, TEK |
7.6099 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALOX15, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, FABP4, HSPA1A, HTR5A, IGF1R, INSR, KDR, MMP2, NR3C1, PPARA, SMAD3, SRC, TEK |
7.53747 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, SRC, TEK |
7.22175 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.11586 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.11586 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FABP3, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
7.09608 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, AR, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, FABP3, HTR5A, IGF1R, INSR, MMP2, NR3C1, PPARA, SMAD3, SRC, TEK |
6.91692 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F10, F3, FABP4, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK, XDH |
6.84177 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
6.79658 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.7705 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.74636 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX15, ALOX5, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, HSPA1A, HTR2B, PPARA, XDH |
6.74156 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AR, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, HTR5A, IGF1R, INSR, MMP2, MMP9, NR3C1, PPARA, SRC, TEK |
6.72271 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
6.67086 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
6.41836 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
6.41836 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
6.3695 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7, SRC, TEK |
6.27568 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC |
6.22233 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
DRD2, DRD3, EGFR, F10, F3, INSR, MET, SRC, TEK, XDH |
6.16978 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
6.16108 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CA2, CA7, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FABP3, FABP4, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
6.16108 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, HTR5A, INSR, NR3C1, PPARA, SRC, TEK |
5.98335 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, DRD1, DRD2, DRD3, DUSP3, EGFR, FABP3, FABP4, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.96768 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.96768 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.95853 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, DRD1, DRD2, DRD3, DUSP3, EGFR, FABP3, FABP4, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
5.92083 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.90758 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.90758 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.67803 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, FABP3, FABP4, GPR35, HTR2A, HTR2B, INSR, MET, SMAD3 |
5.64294 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
5.64294 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
5.64294 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
5.58281 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, AR, DRD2, DUSP3, EGFR, HTR2A, HTR2B, IGF1R, INSR, KDR, SRC, TEK, XDH |
5.57373 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, HCAR2, HSD11B1, HSD17B1, HTR1A, HTR2A |
5.56434 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD2, EGFR, FABP3, FABP4, FUT7, MET, PPARA |
5.55582 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, ALOX15, AR, DRD2, EGFR, HTR2A, HTR2B, INSR, KDR, SRC, TEK, XDH |
5.5551 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR5A, NR3C1, SRC, TEK |
5.54138 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
5.51689 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
5.49026 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, HTR2A, HTR2B, KDR, NR3C1, SRC |
5.48309 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
5.47986 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, EGFR, HTR2A, HTR2B, KDR, SRC, TEK |
5.37437 |
[BP] GO:0030335 |
positive regulation of cell migration
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.31791 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, CSNK2A1, DRD2, DRD3, EGFR, F3, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP2, MMP9, TEK |
5.29874 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, ALOX15, DRD2, DUSP3, EGFR, HTR2A, HTR2B, KDR, SRC, TEK |
5.2912 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
5.28953 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, ALOX15, ALOX5, AR, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FABP4, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, INSR, MET, MMP1, MMP2, MMP9, PPARA, SMAD3, SRC, TEK |
5.2832 |
[BP] GO:2000147 |
positive regulation of cell motility
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.18037 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC |
5.14334 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, AR, CA1, CA2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SIGMAR1, SMAD3, SRC, TEK |
5.13623 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.08192 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
5.07179 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
5.06883 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
5.03762 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2, HTR2A, HTR2B, KDR, SRC |
5.03706 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA |
5.03226 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
5.02835 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, FABP3, FABP4, GPR35, HTR2A, HTR2B, INSR, MET, SMAD3, SRC |
5.00715 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HTR2A |
4.9802 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HTR2A |
4.9802 |
[BP] GO:0040017 |
positive regulation of locomotion
|
DRD1, EGFR, F10, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
4.93727 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.90896 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.89187 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FABP4, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
4.88656 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, DRD1, DRD2, EGFR, FABP3, HTR2A, HTR2B, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
4.87773 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, DRD1, DRD2, EGFR, FABP3, HTR2A, HTR2B, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
4.87773 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, AR, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
4.69858 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AR, DRD1, DRD2, DRD3, DUSP3, EGFR, GPR35, HSPA1A, HTR2A, IGF1R, MET, MMP9, SMAD3, SRC, XDH |
4.69124 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, HSD11B1, HSD17B1 |
4.6835 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, AR, DRD1, DRD2, DRD3, DUSP3, EGFR, GPR35, HSPA1A, HTR2A, IGF1R, MET, MMP9, SMAD3, SRC, XDH |
4.6835 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HSPA1A, HTR2A, HTR2B, MMP2, PPARA, SMAD3, SRC, TEK |
4.6835 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, CA2, DRD1, DRD2, DRD3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, INSR, SIGMAR1, SRC |
4.6835 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, AR, CA2, CA6, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, F10, F3, FABP3, FABP4, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, PPARA, SMAD3, SRC, TEK |
4.64986 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, CYP1A1, DRD2, EGFR, PPARA, SMAD3 |
4.64794 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, F10, F3, GPR35, HSPA1A, HTR2A, HTR2B, HTR6, IGF1R, INSR, KDR, MET, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
4.64704 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, HSPA1A |
4.63805 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.63805 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, CA2, CA7, DRD1, DRD2, EGFR |
4.61566 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR1A, INSR, SMAD3 |
4.59645 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, CSNK2A1, CYP1B1, EGFR, F3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, SIGMAR1, SMAD3, SRC, TEK, XDH |
4.53759 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
4.51395 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, ALOX15, AR, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, IGF1R, MET, MMP9, PPARA, SMAD3, SRC, TEK, XDH |
4.50667 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, AR, DRD1, DRD2, DUSP3, EGFR, FABP4, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, PPARA, SRC, TEK, XDH |
4.42866 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, FABP3, GPR35, HTR2A, HTR2B, SMAD3 |
4.4226 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, CSNK2A1, CYP1B1, EGFR, F3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, SIGMAR1, SMAD3, SRC, TEK, XDH |
4.36691 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, CA2, CA7, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, INSR, MMP9, PPARA, SMAD3, SRC |
4.35647 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, HTR2A, HTR2B, SRC, TEK |
4.3425 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, HCAR2, HTR2A, HTR2B, PPARA, SRC, TEK |
4.3425 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, AR, DRD1, DRD2, DUSP3, EGFR, FABP4, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, SRC, TEK, XDH |
4.30052 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, PPARA, SMAD3, SRC, TEK |
4.25145 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
4.15799 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
4.12751 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, AR, CSNK2A1, DRD1, DRD2, DRD3, DUSP3, EGFR, F3, FABP4, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
4.09434 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, AR, DRD2, DRD3, PPARA, SMAD3 |
4.06095 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, ALOX15, AR, DRD1, DRD2, DUSP3, EGFR, FABP4, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, SRC, TEK, XDH |
4.05851 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
EGFR, F10, F3, INSR, MET, SRC, TEK |
4.01096 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.9767 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA |
3.97441 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, AR, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, F3, FABP4, GPR35, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, MET, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.95835 |
[BP] GO:0051701 |
interaction with host
|
EGFR, HSPA1A, HTR2A, INSR, MET, SMAD3, SRC |
3.91145 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX15, ALOX5, AR, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, FABP3, FABP4, FUT7, HSD17B1, HSPA1A, HTR1A, HTR2B, IGF1R, INSR, KDR, MET, MMP1, MMP2, NR3C1, NR3C2, NUAK1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
3.90995 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, AR, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, SMAD3, SRC |
3.88147 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, DRD1, DRD2, DRD3, EGFR, HTR2B, HTR5A, KDR |
3.85353 |
[BP] GO:0007202 |
None
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.83241 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, CA12, CA2, CA7, DRD1, DRD2, DRD3, EGFR, GPR35, HTR2A, HTR2B, SMAD3 |
3.82814 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AR, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, HSD11B1, INSR, KDR, PPARA, SMAD3, SRC, TEK |
3.82398 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, CSNK2A1, CYP1B1, EGFR, F3, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MMP9, SIGMAR1, SMAD3, SRC, TEK, XDH |
3.81068 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, HSD11B1, HTR5A, INSR, KDR, MMP9, PGR, PPARA, SIGMAR1, SMAD3, SRC, TEK |
3.7885 |
[BP] GO:0050678 |
None
|
AR, EGFR, F3, HTR2B, KDR, PGR, SMAD3, TEK, XDH |
3.76507 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALOX15, AR, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, FABP4, FUT7, HSD11B1, HTR2A, HTR2B, HTR5A, INSR, KDR, MET, MMP2, MMP9, PGR, PPARA, SIGMAR1, SMAD3, SRC, TEK |
3.76507 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, F3, FABP4, KDR, MET, PPARA, SMAD3, TEK |
3.73646 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR, HTR2A |
3.72827 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, AR, CA2, CYP1B1, DRD2, DRD3, EGFR, F3, HCAR2, HSPA1A, HTR2A, HTR2B, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.70923 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.62429 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.62429 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, NR3C1, SRC |
3.60878 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, ALOX15, AR, DRD2, EGFR, HTR2A, HTR2B, INSR, KDR, MMP9, SRC, TEK, XDH |
3.59347 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.57843 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.57018 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, DRD3, HTR1A |
3.55666 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET |
3.51486 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD11B1, HSD17B1 |
3.51425 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.50106 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.49696 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.47787 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, CSNK2A1, DRD1, DRD2, DRD3, EGFR, F3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
3.46895 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.46658 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A |
3.4347 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, HTR2A, HTR2B, PPARA, SRC, TEK |
3.43085 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, ALOX15, DRD1, EGFR, HTR1A, HTR2A, HTR2B, HTR7 |
3.42286 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, CSNK2A1, DRD2, EGFR, F3, HSPA1A, HTR2A, HTR2B, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
3.42286 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, ALOX15, AR, DRD2, EGFR, HTR2A, HTR2B, INSR, KDR, MMP9, SRC, TEK, XDH |
3.40862 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, PPARA |
3.39143 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR, HTR6 |
3.39122 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CYP19A1, DRD2, DUSP3, EGFR, F3, FABP4, HSPA1A, IGF1R, MET, MMP2, NUAK1, PPARA, SMAD3, SRC, TEK, XDH |
3.3865 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, PPARA, SMAD3, TEK |
3.3865 |
[BP] GO:0046777 |
protein autophosphorylation
|
CSNK2A1, EGFR, IGF1R, INSR, KDR, SRC, TEK |
3.3865 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, CSNK2A1, EGFR, HSPA1A, HTR2B, IGF1R, KDR, MMP9, SMAD3, SRC, TEK |
3.3865 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, HTR2A, HTR2B, SRC, TEK |
3.36575 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.35947 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.35347 |
[BP] GO:0048511 |
rhythmic process
|
CSNK2A1, DRD2, DRD3, EGFR, HTR7, PGR, PPARA, SRC |
3.3432 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR2B, SRC |
3.33051 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA, SRC |
3.32627 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, AR, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, FABP3, FABP4, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
3.29504 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SMAD3, SRC, TEK |
3.27585 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
3.26829 |
[BP] GO:0021885 |
forebrain cell migration
|
DRD1, DRD2, EGFR, HTR6 |
3.26519 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.24298 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, DRD1, DRD2, DRD3, EGFR, F3, FABP3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
3.22628 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
3.22269 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, HTR1A |
3.22269 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, AR, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, PGR, TEK |
3.22146 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, EGFR, GPR35, HTR2A, HTR2B, SMAD3 |
3.21034 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, XDH |
3.2051 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, CSNK2A1, DRD1, DRD2, DRD3, EGFR, F3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
3.19686 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, EGFR, FABP3, IGF1R, INSR, MMP2, PPARA, SRC, TEK |
3.19651 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR2A, HTR2B, HTR5A, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK |
3.18495 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, DRD2, EGFR, F3, HSPA1A, HTR2A, HTR2B, INSR, KDR, MMP9, SMAD3, SRC, TEK, XDH |
3.17179 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, CSNK2A1, DRD1, DRD2, DRD3, EGFR, F3, FABP3, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
3.16687 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, DRD2, DRD3, DUSP3, HSPA1A, IGF1R, MET, MMP9, SRC, XDH |
3.16277 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, EGFR, NR3C1, SRC |
3.16277 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, DRD2, DRD3, GPR35, HTR2A, MMP9 |
3.16277 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, DRD2, DRD3, EGFR, GPR35, HCAR2, HTR2A, SMAD3 |
3.15225 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, AR, CYP1A1, CYP1B1, DRD1, EGFR, FABP4, IGF1R, INSR, KDR, MMP2, NR3C1, SMAD3, SRC |
3.12775 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, ALOX15, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, HTR1A |
3.09832 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
3.09802 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, EGFR, GPR35, HTR2A, HTR2B, SMAD3 |
3.06859 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.05595 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2 |
3.05595 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
3.05595 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
3.05595 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 |
3.04217 |
[BP] GO:0007200 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B |
3.03689 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
3.0018 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.99393 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.96824 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.96824 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.96824 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.96824 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.95728 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2A, HTR2B, SRC |
2.93494 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, HCAR2, HTR2B, INSR, SMAD3, SRC |
2.92582 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, DRD1, DRD2, DRD3, EGFR, FABP3, IGF1R, INSR, MMP2, PPARA, SRC, TEK |
2.9184 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.88269 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, HTR2A, HTR2B, IGF1R, INSR, SRC |
2.86871 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, GPR35, HTR2A, HTR2B, SMAD3 |
2.86871 |
[BP] GO:0016477 |
cell migration
|
CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC, TEK |
2.85492 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, AR, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, PGR, TEK |
2.85492 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, MMP1, MMP2, MMP9, SRC, XDH |
2.80714 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.80714 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.80714 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, NR3C1, NR3C2, PGR, PPARA, SRC |
2.80714 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, GPR35, HTR2A, HTR2B, SMAD3 |
2.79093 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AR, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, FABP3, FABP4, GPR35, HSPA1A, HTR2A, HTR2B, IGF1R, KDR, MET, MMP9, NR3C1, PPARA, SMAD3, SRC, TEK, XDH |
2.78639 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.78483 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.77353 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, HTR2B, SRC |
2.77353 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
EGFR, HSPA1A, HTR2A, MET, SRC |
2.77353 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
EGFR, HSPA1A, HTR2A, MET, SRC |
2.77353 |
[BP] GO:0030260 |
entry into host cell
|
EGFR, HSPA1A, HTR2A, MET, SRC |
2.77353 |
[BP] GO:0044409 |
entry into host
|
EGFR, HSPA1A, HTR2A, MET, SRC |
2.77353 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, PPARA, SMAD3, TEK |
2.76515 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.75243 |
[BP] GO:0033993 |
response to lipid
|
AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, HTR5A, NR3C1, SRC |
2.75075 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DUSP3, FABP4, GPR35, IGF1R, MET, MMP9, PPARA, SRC |
2.74594 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, AR, DRD2, DRD3, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.72691 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, AR, CA2, CYP1B1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, XDH |
2.72646 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA1A, ALOX15, ALOX5, AR, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, EGFR, F10, FABP3, HSPA1A, HTR2A, HTR2B, MMP9, PPARA, SIGMAR1, SRC, XDH |
2.72227 |
[BP] GO:0050679 |
None
|
AR, EGFR, F3, HTR2B, KDR, TEK |
2.71943 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, EGFR, HCAR2, HTR2B, MET, PPARA, SMAD3 |
2.70599 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CYP19A1, DRD2, EGFR, HCAR2, HTR1A, HTR2A |
2.70599 |
[BP] GO:0040011 |
locomotion
|
CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MET, MMP1, MMP9, SRC, TEK |
2.69849 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.69849 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, HTR1A, HTR2A, HTR2B, SRC |
2.69639 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.68495 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
2.67709 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1 |
2.66061 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, CYP1B1, EGFR, MMP9, SRC |
2.66061 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, CA2, CA7, DRD1, DRD2, DRD3, GPR35, HTR1A, HTR2A, MMP9 |
2.65848 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.64585 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.64585 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, AR, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, F3, FABP3, FABP4, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
2.64585 |
[BP] GO:0050890 |
None
|
ADORA1, DRD1, DRD2, DRD3, EGFR, HTR2A, INSR |
2.63062 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.62951 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.62951 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.62951 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.62951 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
2.62951 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA1A, ALOX15, AR, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, F3, FABP4, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MMP9, NUAK1, SMAD3, SRC, TEK, XDH |
2.62607 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.62599 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, ALOX15, AR, DRD2, EGFR, HTR2A, HTR2B, INSR, KDR, MMP9, SRC, TEK, XDH |
2.61677 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AR, CYP1B1, DRD1, EGFR, IGF1R, INSR, MMP2, MMP9, NR3C1, SRC |
2.61601 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, GPR35, HTR2A, HTR2B, SMAD3 |
2.59228 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, CYP1B1, DRD1, DRD2, DRD3, EGFR, HTR1A, HTR2A, HTR2B, HTR7, INSR, SRC, TEK |
2.58155 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, SRC, TEK |
2.5805 |
[BP] GO:0001503 |
ossification
|
ALOX15, EGFR, MMP2, MMP9, TEK |
2.57795 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
2.57795 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.57795 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.57795 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.56248 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, CA2, CA9, EGFR, MET, SMAD3, SRC |
2.55928 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, CYP1B1, DRD1, EGFR, KDR, NR3C1, SRC |
2.55928 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, CSNK2A1, EGFR, HCAR2, HSPA1A, HTR2A, HTR2B, INSR, KDR, MET, PPARA, SMAD3 |
2.55172 |
[BP] GO:0048870 |
cell motility
|
CYP1B1, DRD1, DRD2, EGFR, FUT7, HTR2B, HTR6, KDR, MMP1, MMP9, SRC, TEK |
2.5393 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, GPR35, HTR2A, HTR2B, SMAD3 |
2.5356 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ADRA1A, ALOX15, ALOX5, AR, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, F10, FABP3, HSPA1A, HTR2A, HTR2B, MMP9, PPARA, SIGMAR1, SRC, XDH |
2.53306 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.5314 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
2.52885 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.52703 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, GPR35, HTR2A, HTR2B, SMAD3 |
2.52322 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, AR, CA1, CA12, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FABP3, FABP4, GPR35, HCAR2, HSD11B1, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SIGMAR1, SMAD3, SRC, TEK, XDH |
2.51932 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, GPR35, HTR2A, HTR2B, SMAD3 |
2.48719 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1 |
2.48216 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, FABP4, HSPA1A, MMP2, PPARA, SMAD3, SRC, TEK |
2.47508 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, SRC |
2.46192 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.45953 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, CA2, CA7, DRD1, DRD2, DRD3, GPR35, HTR2A, HTR2B, SMAD3 |
2.45547 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD2, EGFR, FABP3, FABP4, MET |
2.45329 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.4239 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.4239 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
2.4239 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.4239 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, DRD1, DRD2, DRD3, EGFR, FABP3, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, NR3C1, PGR, PPARA, SMAD3, SRC |
2.41995 |
[BP] GO:0060402 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.41806 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.40996 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.38986 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.38986 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.37879 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.37879 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.37879 |
[BP] GO:0007610 |
None
|
DRD1, DRD2, DRD3, EGFR, HTR1A, HTR2A, HTR2B, INSR, PPARA |
2.36985 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
EGFR, IGF1R, INSR, KDR, MET, MMP2, MMP9, SMAD3, SRC, TEK |
2.36116 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, AR, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, FABP4, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, NR3C1, NUAK1, SMAD3, SRC |
2.35759 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.35357 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, EGFR, GPR35, HTR2A, HTR2B, SMAD3 |
2.34536 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA1A, ALOX15, AR, CA9, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, F3, FABP3, FABP4, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
2.33541 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7 |
2.33539 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.33539 |
[BP] GO:0045913 |
None
|
HTR2A, INSR, PPARA, SRC |
2.33442 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AR, DRD1, EGFR, IGF1R, INSR, MMP2, NR3C1, SMAD3, SRC |
2.32439 |
[BP] GO:0001936 |
None
|
F3, HTR2B, KDR, TEK, XDH |
2.3207 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.29146 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.29146 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.29146 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, HTR7, PPARA |
2.28083 |
[BP] GO:0007189 |
None
|
ADRA1A, DRD1, DRD2, DRD3 |
2.24801 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AR, CYP1B1, DRD2, FABP3, HSPA1A, SMAD3, XDH |
2.23161 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, DRD2, DUSP3, EGFR, FABP4, HTR2A, HTR2B, IGF1R, INSR, SRC, TEK |
2.23064 |
[BP] GO:0030534 |
None
|
DRD1, DRD2, DRD3, HTR2A, PPARA |
2.22727 |
[BP] GO:0071383 |
None
|
AR, EGFR, NR3C1, SRC |
2.21205 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.21205 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.21205 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.21205 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.21205 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.21205 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.21205 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.21205 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.21205 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.21205 |
[BP] GO:0032413 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.19623 |
[BP] GO:0032845 |
None
|
ADORA1, DRD2, HTR2A, HTR2B, SRC |
2.18462 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, AR, CA1, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FABP3, FABP4, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SIGMAR1, SMAD3, SRC, TEK, XDH |
2.18227 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, AR, DRD2, DRD3, DUSP3, EGFR, HSPA1A, IGF1R, MET, MMP9, SMAD3, SRC, XDH |
2.17947 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.17947 |
[BP] GO:0060401 |
None
|
ADRA1A, DRD2, HTR2A, HTR2B |
2.17947 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, DRD2, DRD3, EGFR, HCAR2, HTR2B, SRC |
2.17654 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
ADRA1A, CSNK2A1, DRD2, EGFR, F3, HSPA1A, HTR2A, HTR2B, MMP9, NUAK1, SMAD3, SRC, XDH |
2.16882 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AR, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7, PGR, TEK |
2.16545 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, DRD3, EGFR, NR3C1 |
2.16543 |
[BP] GO:1900542 |
None
|
DRD1, DRD2, DRD3, HTR2A, INSR, PPARA |
2.16406 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, PPARA, SMAD3 |
2.16406 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, EGFR, HCAR2, HTR2B, SRC |
2.15647 |
[BP] GO:0007611 |
None
|
DRD1, DRD2, DRD3, EGFR, HTR2A, INSR |
2.15647 |
[BP] GO:2000116 |
regulation of cysteine-type endopeptidase activity
|
CSNK2A1, F3, MMP9, SMAD3, SRC, XDH |
2.1475 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, NR3C1, PGR, SRC |
2.14667 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, AR, CYP19A1 |
2.14203 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.14203 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, AR, CA9, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, F3, FABP3, FABP4, HSPA1A, HTR1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
2.14141 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AR, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, EGFR, FABP4, HCAR2, HSPA1A, HTR2B, IGF1R, KDR, MET, MMP9, NR3C1, PGR, PPARA, SMAD3, SRC, XDH |
2.13332 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, ALOX5, AR, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FABP3, FABP4, FUT7, GPR35, HCAR2, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SIGMAR1, SMAD3, SRC, TEK, XDH |
2.12877 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, AR, DRD2, EGFR, F3, HSPA1A, HTR2A, HTR2B, INSR, MET, MMP9, SMAD3, SRC, TEK, XDH |
2.12455 |
[BP] GO:0006140 |
None
|
DRD1, DRD2, DRD3, HTR2A, INSR, PPARA |
2.10854 |
[BP] GO:1901890 |
None
|
KDR, SMAD3, TEK |
2.10854 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.10854 |
[BP] GO:0014065 |
phosphatidylinositol 3-kinase signaling
|
HTR2A, HTR2B, IGF1R |
2.10854 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.10854 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3 |
2.10211 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, HSPA1A, HTR1A, MMP2, MMP9, NUAK1, PPARA, SMAD3, SRC, TEK |
2.09438 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, FABP3, IGF1R, INSR, PPARA, SRC, TEK |
2.09438 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AR, CYP1A1, CYP1B1, DRD1, EGFR, NR3C1, SRC |
2.08127 |
[BP] GO:1901888 |
regulation of cell junction assembly
|
KDR, SMAD3, SRC, TEK |
2.08127 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
EGFR, INSR, KDR, NR3C1, SMAD3, SRC |
2.08127 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.08127 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.08127 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.08127 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.08127 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX15, ALOX5 |
2.08127 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6 |
2.08127 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, HSPA1A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, SRC, TEK, XDH |
2.0803 |
[BP] GO:0032410 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.07195 |
[BP] GO:1904063 |
None
|
DRD2, DRD3, GPR35, MMP9 |
2.07195 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, CA2, CA9, EGFR, MET, SMAD3, SRC |
2.06544 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, DRD1, DRD2, GPR35, HTR2A, HTR2B |
2.06405 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, DRD2, EGFR, HCAR2, HTR2B, SRC |
2.05997 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AR, DRD1, DRD2, DRD3, EGFR, FABP3, HTR2A, HTR2B, IGF1R, INSR, MET, NR3C1, PGR, PPARA, SMAD3, SRC |
2.0525 |
[BP] GO:0010907 |
None
|
INSR, PPARA, SRC |
2.05127 |
[BP] GO:0045907 |
None
|
ADRA1A, EGFR, HTR2A |
2.05127 |
[BP] GO:0060191 |
regulation of lipase activity
|
ADRA1A, EGFR, HTR2A, HTR2B |
2.03977 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, NR3C1, NR3C2, PGR, PPARA |
2.02468 |
[BP] GO:0001938 |
None
|
F3, HTR2B, KDR, TEK |
2.02284 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ADRA1A, ALOX15, ALOX5, AR, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, DRD1, DRD2, DRD3, EGFR, F10, FABP3, HSPA1A, HTR2A, HTR2B, MMP9, PPARA, SIGMAR1, SRC, XDH |
2.02284 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALOX15, AR, CA1, CA2, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FABP3, FABP4, GPR35, HCAR2, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SIGMAR1, SMAD3, SRC, TEK, XDH |
2.01967 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, DRD1, DRD2, DRD3, GPR35, HTR2A, HTR2B, SMAD3 |
2.01967 |
[BP] GO:0044089 |
positive regulation of cellular component biogenesis
|
ALOX15, HSPA1A, KDR, MET, MMP1, SMAD3, SRC, TEK |
2.01458 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, F10, F3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
5.80884 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, ALOX15, CA2, CA9, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, SRC, TEK |
5.22108 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, GPR35, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
4.82607 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, CA12, CA14, CA2, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, F10, F3, FUT7, GPR35, HCAR2, HSD11B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MPEG1, NR3C2, SIGMAR1, SRC, TEK |
4.15802 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, ALOX5, AR, CA12, CA14, CA2, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, F10, F3, FUT7, GPR35, HCAR2, HSD11B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, NR3C2, PGR, SIGMAR1, SMAD3, SRC, TEK |
4.12751 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX15, AR, CA12, CA14, CA2, CA9, CSNK2A1, DRD1, DRD2, DRD3, EGFR, F10, F3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, MMP2, SMAD3, SRC, TEK |
4.1006 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA9, DRD1, DRD2, EGFR, HTR2A, INSR, MET, SIGMAR1, SRC, TEK |
2.86331 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, EGFR, HSD11B1, NR3C2, SIGMAR1 |
2.53608 |
[CC] GO:0045121 |
membrane raft
|
ADRA1A, EGFR, HTR2A, INSR, KDR, SRC, TEK |
2.47291 |
[CC] GO:0098857 |
membrane microdomain
|
ADRA1A, EGFR, HTR2A, INSR, KDR, SRC, TEK |
2.45819 |
[CC] GO:0005901 |
caveola
|
ADRA1A, HTR2A, INSR, SRC |
2.27058 |
[CC] GO:0098589 |
membrane region
|
ADRA1A, EGFR, HTR2A, INSR, KDR, SRC, TEK |
2.07195 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
14.542 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AR, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, SMAD3, XDH |
12.9474 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, AR, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, EGFR, F10, F3, FABP3, FABP4, HSD17B1, HSPA1A, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SMAD3, SRC, TEK, XDH |
11.5107 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AR, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, SIGMAR1, TEK |
10.7064 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AR, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, SIGMAR1, TEK |
9.54654 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AR, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, SIGMAR1, SMAD3, TEK |
9.48271 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
9.48271 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AR, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, NR3C1, NR3C2, PGR, PPARA, SIGMAR1, TEK |
9.35403 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.54666 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
8.52313 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
8.46468 |
[MF] GO:0008227 |
None
|
ADRA1A, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.85626 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, AR, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD1, DRD2, DRD3, F10, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SMAD3, XDH |
7.81952 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
7.56319 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, INSR, KDR, MET, SIGMAR1, TEK |
7.56319 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.22175 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
7.17841 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, XDH |
7.12096 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.11586 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
7.11586 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.08479 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.08479 |
[MF] GO:0008144 |
drug binding
|
ACHE, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD1, DRD2, DRD3, EGFR, HSPA1A, HTR2A, HTR2B, IGF1R, INSR, KDR, MET, NUAK1, PPARA, SIGMAR1, SRC, TEK |
6.70818 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, MMP1, MMP2, MMP9, NR3C1, NR3C2, PGR, PPARA, SMAD3 |
6.49849 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.01792 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.64105 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
5.57373 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.56434 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, HSD17B1, IGF1R, INSR, NR3C1 |
5.48586 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC |
5.3638 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
5.3371 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
5.20508 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.96034 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX15, ALOX5, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, F10, F3, FUT7, HSD11B1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP2, MMP9, NUAK1, SRC, TEK, XDH |
4.90963 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.79321 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, DRD1, DRD2, DRD3, GPR35, HCAR2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
4.6835 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, TEK |
4.4226 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, XDH |
4.0442 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
3.96205 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, NR3C1, NR3C2, PGR, PPARA |
3.72827 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
EGFR, IGF1R, INSR, KDR, MET, SRC, TEK |
3.57018 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.47787 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, SRC, XDH |
3.37254 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, AR, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, F10, MMP1, MMP2, MMP9, NR3C1, NR3C2, NUAK1, PGR, PPARA, SMAD3, XDH |
3.29504 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.15038 |
[MF] GO:0005496 |
steroid binding
|
AR, HSD17B1, NR3C1, NR3C2, PGR |
3.05595 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
3.05595 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
3.01394 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, F10, F3, FABP3, FABP4, HSD17B1, NR3C1, NR3C2, PGR, PPARA |
2.96726 |
[MF] GO:0031072 |
heat shock protein binding
|
ADORA1, CSNK2A1, HSPA1A, KDR, NR3C1 |
2.70601 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.57795 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, EGFR, HTR2A, IGF1R, INSR, KDR, MMP9, PPARA, SMAD3, SRC |
2.45329 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, IGF1R, INSR, KDR, TEK |
2.35759 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, HTR2A, IGF1R, INSR, KDR, MMP9, PPARA, SMAD3, SRC |
2.29146 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.21205 |
[MF] GO:0051879 |
Hsp90 protein binding
|
CSNK2A1, KDR, NR3C1 |
2.08127 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.08127 |